Uncategorized
- Job Title: Policy and Public Affairs Officer
- Position Type: Full time/permanent
- Location: Brussels, Belgium
- Travel required: 30 days / year (approx.)
- Gross salary: 35,000 – 40,000 EUR/year
The world’s largest haematology conference will be held in person and virtually this year from the 11th to 14th of December. Despite the continued difficulties and limitations posed by the coronavirus pandemic, this year’s American Society of Haematology Annual Meeting will feature, more than 200 abstracts in myeloma and AL amyloidosis. Continue reading
Myeloma Patients Europe (MPE) is seeking research grant applications, for funding of up to 100k €, on a project exploring shared-decision making in myeloma.
If you are interested, please read the information below and complete the following application form. Deadline for submission is 3 pm CET on Friday 5th of November 2021
Myeloma Patients Europe (MPE) will hold a webinar to review the most recent updates on the approved COVID-19 vaccines in Europe and how they affect myeloma and AL amyloidosis patients. Continue reading
As part of the CARAMBA consortium, Myeloma Patients Europe (MPE) has developed an information sheet to explain the main goals and characteristics of the CARAMBA clinical trial investigating SLAMF7 chimeric antigen receptor T-cell (CAR-T) therapy. This publication discusses some potential CAR-T side effects and considerations for patients and caregivers. This information sheet has been previously published on our website in English and is now available in four additional languages: French, Italian, Spanish and German. Continue reading
Location: European Union or United Kingdom / home based
Contract: Full-time (part time also possible)
Location: European Union or United Kingdom / home based
Contract: Full-time (part time also possible) Continue reading
Location: Scotland / home based (approx. 10 travel days per year)
Contract: 40 hours per week / permanent
Salary: £25,000 – £27,000 depending on experience
This Research Assistant post supports the research function of Myeloma Patients Europe (MPE). There are two main elements to the job – supporting communication and dissemination of SISAQOL-IMI and to assist with generating patient centred evidence as part of MPE’s newly established Evidence Generation Unit (EGU). The following tasks and core responsibilities are non-exhaustive and subject to change depending on needs of the organisation.
Location: European Union or United Kingdom / home based (approx. 15 travel days per year)
Contract: Full-time (part time also possible) / permanent
Salary: 40.000 EUR/year GROSS
Myeloma Patients Europe (MPE) has put together an advice sheet for our members and myeloma patients on coronavirus (Covid-19). This advice has been reviewed by our scientific advisors and will be continually updated to reflect the latest information.